Impact of Changing the Dosing Regimen on the PK Profile of ODM-203
Clinical trial NCT03240445 · COMPLETED
Trial details
- NCT number
- NCT03240445
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2017-10-23
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.